Annual EPS
-$2.02
+$0.42+17.21%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual earnings per share is currently -$2.02, with the most recent change of +$0.42 (+17.21%) on 31 December 2023. During the last 3 years, it has risen by +$2.54 (+55.70%). PRLD annual EPS is now -341.82% below its all-time high of -$0.46, reached on 31 December 2018.PRLD EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.43
+$0.03+6.52%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly earnings per share is currently -$0.43, with the most recent change of +$0.03 (+6.52%) on 30 September 2024. Over the past year, it has increased by +$0.02 (+4.44%). PRLD quarterly EPS is now -106.93% below its all-time high of -$0.21, reached on 30 September 2019.PRLD Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$1.78
+$0.02+1.11%
30 September 2024
Summary:
Prelude Therapeutics Incorporated TTM earnings per share is currently -$1.78, with the most recent change of +$0.02 (+1.11%) on 30 September 2024. Over the past year, it has increased by +$0.39 (+17.97%). PRLD TTM EPS is now -756.59% below its all-time high of -$0.21, reached on 30 September 2019.PRLD TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.2% | +4.4% | +18.0% |
| 3 y3 years | +55.7% | +34.9% | +17.2% |
| 5 y5 years | -341.8% | -106.9% | -756.6% |
PRLD EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.7% | -2.4% | +39.4% | at high | +31.0% |
| 5 y | 5 years | -341.8% | +55.7% | -106.9% | +91.8% | -756.6% | +73.6% |
| alltime | all time | -341.8% | +55.7% | -106.9% | +91.8% | -756.6% | +73.6% |
Prelude Therapeutics Incorporated EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.43(-6.5%) | -$1.78(-1.1%) |
| June 2024 | - | -$0.46(+9.5%) | -$1.80(-4.3%) |
| Mar 2024 | - | -$0.42(-10.6%) | -$1.88(-7.8%) |
| Dec 2023 | -$2.02(-17.2%) | -$0.47(+4.4%) | -$2.04(-6.0%) |
| Sept 2023 | - | -$0.45(-16.7%) | -$2.17(-7.7%) |
| June 2023 | - | -$0.54(-6.9%) | -$2.35(-1.7%) |
| Mar 2023 | - | -$0.58(-3.3%) | -$2.39(-2.0%) |
| Dec 2022 | -$2.44(+0.4%) | -$0.60(-4.8%) | -$2.44(-4.3%) |
| Sept 2022 | - | -$0.63(+8.6%) | -$2.55(-1.2%) |
| June 2022 | - | -$0.58(-7.9%) | -$2.58(0.0%) |
| Mar 2022 | - | -$0.63(-11.3%) | -$2.58(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$2.43(-46.7%) | -$0.71(+7.6%) | -$2.42(+12.5%) |
| Sept 2021 | - | -$0.66(+13.8%) | -$2.15(-68.1%) |
| June 2021 | - | -$0.58(+23.4%) | -$6.74(+4.8%) |
| Mar 2021 | - | -$0.47(+6.7%) | -$6.43(+2.8%) |
| Dec 2020 | -$4.56(+435.9%) | -$0.44(-91.6%) | -$6.25(+2.1%) |
| Sept 2020 | - | -$5.25(+1853.9%) | -$6.12(+467.0%) |
| June 2020 | - | -$0.27(-8.4%) | -$1.08(+33.1%) |
| Mar 2020 | - | -$0.29(-5.3%) | -$0.81(+56.7%) |
| Dec 2019 | -$0.85(+86.1%) | -$0.31(+49.1%) | -$0.52(+149.1%) |
| Sept 2019 | - | -$0.21 | -$0.21 |
| Dec 2018 | -$0.46 | - | - |
FAQ
- What is Prelude Therapeutics Incorporated annual earnings per share?
- What is the all time high annual EPS for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual EPS year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly earnings per share?
- What is the all time high quarterly EPS for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly EPS year-on-year change?
- What is Prelude Therapeutics Incorporated TTM earnings per share?
- What is the all time high TTM EPS for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated TTM EPS year-on-year change?
What is Prelude Therapeutics Incorporated annual earnings per share?
The current annual EPS of PRLD is -$2.02
What is the all time high annual EPS for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual earnings per share is -$0.46
What is Prelude Therapeutics Incorporated annual EPS year-on-year change?
Over the past year, PRLD annual earnings per share has changed by +$0.42 (+17.21%)
What is Prelude Therapeutics Incorporated quarterly earnings per share?
The current quarterly EPS of PRLD is -$0.43
What is the all time high quarterly EPS for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly earnings per share is -$0.21
What is Prelude Therapeutics Incorporated quarterly EPS year-on-year change?
Over the past year, PRLD quarterly earnings per share has changed by +$0.02 (+4.44%)
What is Prelude Therapeutics Incorporated TTM earnings per share?
The current TTM EPS of PRLD is -$1.78
What is the all time high TTM EPS for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high TTM earnings per share is -$0.21
What is Prelude Therapeutics Incorporated TTM EPS year-on-year change?
Over the past year, PRLD TTM earnings per share has changed by +$0.39 (+17.97%)